Literature DB >> 5134286

Atropine-induced changes of cerebral dopamine turnover.

G Bartholini, A Pletscher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5134286     DOI： 10.1007/BF02136701

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  6 in total

1.  Dissociation between biochemical and ultrastructural effects of 6-hydroxydopamine in rat brain.

Authors:  G Bartholini; J G Richards; A Pletscher
Journal:  Experientia       Date:  1970

2.  Influences of cholinergic mechanisms on the function and turnover of brain dopamine.

Authors:  N E Andén; P Bédard
Journal:  J Pharm Pharmacol       Date:  1971-06       Impact factor: 3.765

3.  A rapid, simplified procedure for simultaneous assay of norepinephrine, dopamine, and 5-hydroxytryptamine from discrete brain areas.

Authors:  M K Shellenberger; J H Gordon
Journal:  Anal Biochem       Date:  1971-02       Impact factor: 3.365

4.  A method for the determination of 5-hydroxyindolyl-3-acetic acid in brain.

Authors:  E Giacalone; L Valzelli
Journal:  J Neurochem       Date:  1966-11       Impact factor: 5.372

5.  The effect of tropolone on the formation of 3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the brain of the mouse.

Authors:  G F Murphy; D Robinson; D F Sharman
Journal:  Br J Pharmacol       Date:  1969-05       Impact factor: 8.739

6.  Effect of drugs used in psychoses on cerebral dopamine metabolism.

Authors:  R O'Keeffe; D F Sharman; M Vogt
Journal:  Br J Pharmacol       Date:  1970-02       Impact factor: 8.739
  6 in total
  8 in total

1.  Acute and subacute effects of neuroleptics dopamine synthesis and release in the rat striatum.

Authors:  B Scatton; C Garret; L Julou
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Are cholinergic mechanisms involved in morphine effects on motility?

Authors:  K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

3.  The role of dopamine in pilocarpine-induced catalepsy.

Authors:  L Ahtee; I Kääriäinen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

4.  A role of the polysynaptic system of substantia nigra in the cholinergic-dopaminergic equilibrium in the central nervous system.

Authors:  S Wolfarth; E Dulska; K Gołembiowska-Nikitin; J Vetulani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-04       Impact factor: 3.000

5.  Acetylcholine induced responses of plasma LH and prolactin in normal and 6-hydroxydopamine-treated rats.

Authors:  A O Donoso; J C Bacha
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

6.  Proceedings: Dopaminergic-cholinergic interaction in the striatum: decrease in rat striatal acetylcholine (ACh) levels by dopaminergic and cholinergic antagonists.

Authors:  S Bianchi; S Consolo; H Ladinsky
Journal:  Br J Pharmacol       Date:  1974-11       Impact factor: 8.739

7.  Effect of muscarinic cholinergic drugs on morphine-induced catalepsy, antinociception and changes in brain dopamine metabolism.

Authors:  S Kaakkola; L Ahtee
Journal:  Psychopharmacology (Berl)       Date:  1977-03-23       Impact factor: 4.530

8.  Effect of mecamylamine on the fate of dopamine in striatal and mesolimbic areas of rat brain; interaction with morphine and haloperidol.

Authors:  L Ahtee; S Kaakkola
Journal:  Br J Pharmacol       Date:  1978-02       Impact factor: 8.739
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.